ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of acute myeloblastic leukaemia (AML) in adult patients.
Fey
M F
MF
Institute of Medical Oncology, Inselspital and University of Berne, Berne, Switzerland.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000379:methods; D003131:Combined Modality Therapy / Q000592:standards; D005260:Female; D005500:Follow-Up Studies; D006287:Health Planning Guidelines; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010347:Patient Care Planning / Q000592:standards*; D012074:Remission Induction / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome